Inspection Findings:
Based on interview and record review, it was determined the facility failed to ensure a resident who self-administered medications was evaluated at least quarterly to ensure they were safe to do so, for 1 of 1 sampled resident (#2) who self-administered medications. Findings include, but are not limited to:Resident 2 was admitted to the facility on 08/2021 with diagnoses including dementia. Review of the resident's 08/30/21 signed physician orders and the October MAR indicated the resident had an order to self-administer Miralax (for bowel care), Glucose tablets (for hypoglycemia) and Ipratropium nasal spray (for allergies). The facility administered all other medications for the resident.There was no documented evidence a self-medication evaluation had been completed by the facility. The need to ensure a quarterly self-medication administration evaluation was completed for each resident who wished to self-administer medications was discussed with Staff 1 (Health Care Services Administrator), Staff 2 (Director of Nursing) and Staff 3 (RN) on 10/19/21. They acknowledged the findings.
Plan of Correction:
1. The facility will evaluate Resident #2 for their ability to safely self-administer medications.2. The facility will audit the Physician's Orders of all residents to identify those with orders to self-administer medication(s). The facility will assure that a Self- Medications Evaluation has been completed within the past 90 days for each resident with an order to self-administer medications.3. Licensed nurses will be re-educated regarding the facility policy regarding self-administration of medication and Self- Medication Evaluations, 4. A monthly audit will by conducted by the DNS or designee to assure that each resident with a physician's order to self-administer medication has a Self-Medication Evaluation completed within the past 90 days. Audit results will be reported to the Quality Assurance Committee and the frequency of future audits adjusted.